Portal:ExRNA/FeaturedPathways
From WikiPathways
(Difference between revisions)
(Added WP4474) |
Current revision (21:17, 13 May 2019) (view source) (removed deleted pathway) |
||
| (3 intermediate revisions not shown.) | |||
| Line 12: | Line 12: | ||
|width=100px|{{#pwImage:Pathway:WP2868|250px||TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer}} | |width=100px|{{#pwImage:Pathway:WP2868|250px||TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer}} | ||
[http://dx.doi.org/10.1002/msb.20134892 Yang et al. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer] | [http://dx.doi.org/10.1002/msb.20134892 Yang et al. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer] | ||
| - | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP3674|250px||mir34a and TGIF2 in osteoclastogenesis}} |
[http://dx.doi.org/10.1038/nature13375 Krzeszinski et al. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2] | [http://dx.doi.org/10.1038/nature13375 Krzeszinski et al. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2] | ||
|width=100px|{{#pwImage:Pathway:WP2811|250px||mir219 in Oligodendrocyte Differentiation and Myelination}} | |width=100px|{{#pwImage:Pathway:WP2811|250px||mir219 in Oligodendrocyte Differentiation and Myelination}} | ||
| Line 37: | Line 37: | ||
[http://www.ncbi.nlm.nih.gov/pubmed/27013343 Parasramka et al. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma] | [http://www.ncbi.nlm.nih.gov/pubmed/27013343 Parasramka et al. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma] | ||
|- | |- | ||
| - | |width=100px|{{#pwimage:Pathway: | + | |width=100px|{{#pwimage:Pathway:WP3926|250px||ApoE and miR-146 in inflammation and atherosclerosis}} |
[http://www.ncbi.nlm.nih.gov/pubmed/25904598 Li et al. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis] | [http://www.ncbi.nlm.nih.gov/pubmed/25904598 Li et al. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis] | ||
|width=100px|{{#pwimage:Pathway:WP3593|250px||miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma}} | |width=100px|{{#pwimage:Pathway:WP3593|250px||miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma}} | ||
| Line 86: | Line 86: | ||
|width=100px|{{#pwimage:Pathway:Pathway:WP4474|250px||Circulating monocytes and cardiac macrophages in diastolic dysfunction}} | |width=100px|{{#pwimage:Pathway:Pathway:WP4474|250px||Circulating monocytes and cardiac macrophages in diastolic dysfunction}} | ||
[https://www.ncbi.nlm.nih.gov/pubmed/29348254 Hulsmans et al, Cardiac macrophages promote diastolic dysfunction] | [https://www.ncbi.nlm.nih.gov/pubmed/29348254 Hulsmans et al, Cardiac macrophages promote diastolic dysfunction] | ||
| + | |width=100px|{{#pwimage:Pathway:Pathway:WP4566|250px||Translational regulation by PDGFRα}} | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/30456354 Zhou et al, Chronic platelet-derived growth factor receptor signaling exerts control over initiation of protein translation in glioma] | ||
| + | |width=100px|{{#pwimage:Pathway:Pathway:WP4560|250px||MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement}} | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/29251630 Leung et al, Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance] | ||
| + | |- | ||
| + | |width=100px|{{#pwimage:Pathway:Pathway:WP4559|250px||Interactions between immune cells and microRNAs in tumor microenvironment}} | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/30578699 Cortez et al, Role of miRNAs in immune responses and immunotherapy in cancer] | ||
|width=100px|{{#pwimage:Pathway:WP2059|250px||Alzheimers Disease}} | |width=100px|{{#pwimage:Pathway:WP2059|250px||Alzheimers Disease}} | ||
|width=100px|{{#pwimage:Pathway:WP2371|250px||Parkinsons Disease}} | |width=100px|{{#pwimage:Pathway:WP2371|250px||Parkinsons Disease}} | ||
| + | |width=100px|{{#pwimage:Pathway:WP2904|250px||Mir302-367 Promoting Cardiomyocyte Proliferation}} | ||
|- | |- | ||
|width=100px|{{#pwImage:Pathway:WP1544|250px||MicroRNAs in cardiomyocyte hypertrophy}} | |width=100px|{{#pwImage:Pathway:WP1544|250px||MicroRNAs in cardiomyocyte hypertrophy}} | ||
| Line 97: | Line 105: | ||
|width=100px|{{#pwimage:Pathway:WP1545|250px||miRNAs involved in DNA damage response}} | |width=100px|{{#pwimage:Pathway:WP1545|250px||miRNAs involved in DNA damage response}} | ||
|width=100px|{{#pwImage:Pathway:WP2249|250px||Metastatic Brain Tumor}} | |width=100px|{{#pwImage:Pathway:WP2249|250px||Metastatic Brain Tumor}} | ||
| - | |width=100px|{{#pwimage:Pathway: | + | |width=100px|{{#pwimage:Pathway:WP673|250px||ErbB Signaling Pathway}} |
|- | |- | ||
|width=100px|{{#pwImage:Pathway:WP2431|250px||Spinal Cord Injury}} | |width=100px|{{#pwImage:Pathway:WP2431|250px||Spinal Cord Injury}} | ||
| Line 134: | Line 142: | ||
|width=100px|{{#pwimage:Pathway:WP2857|250px||Mesodermal Commitment Pathway}} | |width=100px|{{#pwimage:Pathway:WP2857|250px||Mesodermal Commitment Pathway}} | ||
|width=100px|{{#pwImage:Pathway:WP1991|250px||SRF and miRs in Smooth Muscle Differentiation and Proliferation}} | |width=100px|{{#pwImage:Pathway:WP1991|250px||SRF and miRs in Smooth Muscle Differentiation and Proliferation}} | ||
| - | |||
| - | |||
| - | |||
|} | |} | ||
Current revision
|
Image does not exist T-Cell Receptor and Co-stimulatory Signaling |
Image does not exist IL1 and megakaryotyces in obesity |
Image does not exist miRNA mechanism of action and biogenesis Ozpolat et al. Liposomal siRNA nanocarriers for cancer therapy Thomas et al. Eri1: a conserved enzyme at the crossroads of multiple RNA-processing pathways |
Image does not exist Extracellular vesicle-mediated signaling in recipient cells |
|
Image does not exist TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer |
Image does not exist mir34a and TGIF2 in osteoclastogenesis |
Image does not exist mir219 in Oligodendrocyte Differentiation and Myelination |
Image does not exist Apoptosis-related network due to altered Notch3 in ovarian cancer |
|
Image does not exist miR-222 in Exercise-Induced Cardiac Growth |
Image does not exist Hypoxia-mediated EMT and Stemness |
Image does not exist DDX1 as a regulatory component of the Drosha microprocessor |
Image does not exist EV release from cardiac cells and their functional effects Danielson and Das, Extracellular Vesicles in Heart Disease: Excitement for the Future? |
|
Image does not exist Rac1/Pak1/p38/MMP-2 pathway Gonzalez-Villasana et al. Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer |
Image does not exist eIF5A regulation in response to inhibition of the nuclear export system Miyake et al. XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A |
Image does not exist MFAP5-mediated ovarian cancer cell motility and invasiveness |
Image does not exist LncRNA-mediated mechanisms of therapeutic resistance Parasramka et al. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma |
|
Image does not exist ApoE and miR-146 in inflammation and atherosclerosis |
Image does not exist miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma |
Image does not exist mir-124 predicted interactions with cell cycle and differentiation |
Image does not exist miR-517 relationship with ARCN1 and USP1 |
|
Image does not exist miR-509-3p alteration of YAP1/ECM axis |
Image does not exist H19 action Rb-E2F1 signaling and CDK-β-catenin activity |
Image does not exist mir-193a and MVP in colon cancer metastasis Teng et al. H19 MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression |
Image does not exist miRNA regulation of p53 pathway in prostate cancer |
|
Image does not exist miRNA regulation of prostate cancer signaling pathways |
Image does not exist LncRNA involvement in canonical Wnt signaling and colorectal cancer Shen et al. To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer |
Image does not exist Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer |
Image does not exist Extracellular vesicles in the crosstalk of cardiac cells Bei et al. Extracellular Vesicles in Cardiovascular Theranostics. |
|
Image does not exist Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells |
Image does not exist miRNAs in the signaling pathway of the immune response in sepsis Giza et al. Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications |
Image does not exist ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
Image does not exist ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
|
Image does not exist PDGFRα and STMN1 cooperate to exacerbate the cytotoxic effects of vinblastine |
Image does not exist Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors |
Image does not exist MicroRNA network associated with Chronic lymphocytic leukemia |
Image does not exist FABP4 in ovarian cancer Gharpure et al, FABP4 as a key determinant of metastatic potential of ovarian cancer |
|
Image does not exist Platelet-mediated interactions with vascular and circulating cells Koupenova et al, Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis |
Image does not exist Circulating monocytes and cardiac macrophages in diastolic dysfunction Hulsmans et al, Cardiac macrophages promote diastolic dysfunction |
Image does not exist Translational regulation by PDGFRα |
Image does not exist MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement |
|
Image does not exist Interactions between immune cells and microRNAs in tumor microenvironment Cortez et al, Role of miRNAs in immune responses and immunotherapy in cancer |
Image does not exist Alzheimers Disease |
Image does not exist Parkinsons Disease |
Image does not exist Mir302-367 Promoting Cardiomyocyte Proliferation |
|
Image does not exist MicroRNAs in cardiomyocyte hypertrophy |
Image does not exist Integrated Lung Cancer Pathway |
Image does not exist miRNA Biogenesis |
Image does not exist miRNA targets in ECM and membrane receptors |
|
Image does not exist Fluoropyrimidine Activity |
Image does not exist miRNAs involved in DNA damage response |
Image does not exist Metastatic Brain Tumor |
Image does not exist ErbB Signaling Pathway |
|
Image does not exist Spinal Cord Injury |
Image does not exist miRNA Regulation of DNA Damage Response |
Image does not exist Parkinsons Disease Pathway (Mus musculus) |
Image does not exist Hepatitis C and Hepatocellular Carcinoma |
|
Image does not exist Metastatic brain tumor |
Image does not exist Role of Osx and miRNAs in tooth development |
Image does not exist miR-127 in mesendoderm differentiation |
Image does not exist Mecp2 and Associated Rett Syndrome |
|
Image does not exist miRs in Muscle Cell Differentiation |
Image does not exist Cell Differentiation |
Image does not exist Signaling Pathways in Glioblastoma |
Image does not exist REBF and miR33 in cholesterol and lipid homeostasis |
|
Image does not exist miR-targeted genes in lymphocytes - TarBase |
Image does not exist miR-targeted genes in muscle cell - TarBase |
Image does not exist miR-targeted genes in leukocytes - TarBase |
Image does not exist miR-targeted genes in squamous cell - TarBase |
|
Image does not exist miR-targeted genes in epithelium - TarBase |
Image does not exist TarBasePathway |
Image does not exist miR-targeted genes in adipocytes - TarBase |
Image does not exist Ectoderm Differentiation |
|
Image does not exist Endoderm Differentiation |
Image does not exist Mesodermal Commitment Pathway |
Image does not exist SRF and miRs in Smooth Muscle Differentiation and Proliferation |
